ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿
ÎÒÃǵķþÎñ

×÷ΪÖйúµÚÈý·½¼ì²âÓëÈÏÖ¤·þÎñµÄ¿ªÍØÕߺÍÁìÏÈÕß £¬NG28ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²âΪȫÇò¿Í»§Ìṩһվʽ¼ìÑé¡¢²âÊÔ¡¢Ð£×¼¡¢ÈÏÖ¤¼°¼¼Êõ·þÎñ¡£

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿
ÐÐÒµ½â¾ö·½°¸

·þÎñÄÜÁ¦ÒÑÈ«ÃæÁýÕÖµ½·ÄÖ¯·þ×°¼°Ð¬°ü¡¢Ó¤Í¯Íæ¾ß¼°¼Ò¾ÓÉú»î¡¢µç×ÓµçÆ÷¡¢Ò½Ñ§½¡¿µ¡¢Ê³Æ·¼°Å©²úÎï……µÈÐÐÒµµÄ¹©Ó¦Á´ÉÏÏÂÓΡ£

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿
ÌØÉ«·þÎñ

È«Ãæ±£ÕÏÆ·ÖÊÓëÄþ¾² £¬Íƶ¯ºÏ¹æÓ봴Р£¬ÕÃÏÔÆ·ÅƾºÕùÁ¦ £¬ÊµÏÖ¸ü¸ßÖÊÁ¿¡¢¸ü½¡¿µ¡¢¸üÄþ¾²¡¢¸üÂÌÉ«µÄ¿ÉÁ¬ÐøÉú³¤¡£

¼ÓÈëÎÒÃÇ
È˲ÅÕþ²ß
ÕÐÏÍÄÉÊ¿
ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿
È˲ÅÕþ²ß
±£ÕÏÔ±¹¤»ù±¾È¨ÒæÓ븣Àû£»Ìṩרҵ¼¼ÄÜÅàѵ £¬´Ù½øÔ±¹¤Éú³¤£»¿ªÕ¹¸»ºñ¶à²ÊµÄ»î¶¯ £¬Æ½ºâÔ±¹¤ÊÂÇéÓëÉú»î¡£
ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿
ÕÐÏÍÄÉÊ¿
»¶Ó­¼ÓÈëÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¼ì²â¸÷ÈËÍ¥ £¬ÎÒÃǽ«ÎªÄã´î½¨Ò»¸ö³äʵʩչ²ÅÆø £¬ÊµÏÖÖ°ÒµÀíÏëµÄÎę̀¡£
ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿
ÐÂÎÅ×ÊѶ

¹¬¾±°©¼×»ù»¯£º·´¿¹³ÁĬµÄÅ®ÐÔÖ×ÁöɱÊÖ

Ðû²¼Ê±¼ä£º2024-01-26 ä¯ÀÀ´ÎÊý£º1010

        ÔçÆÚ×Ó¹¬¾±°©Í¨³£Ã»ÓГÃ÷ÏÔÖ¢×´” £¬Å®ÐԸ߷¢Ö×Áö³ÁĬµÄɱÊÖ¡£Òò´Ë £¬·¢ÏÖ¹¬¾±°©²»½öÒÀÀµÓÚ·ºÆðÖ¢×´ £¬¸üÖØÔÚ½øÐй¬¾±°©É¸²é¡£¹¬¾±°©²¡ÒòÃ÷È· £¬·ÀÖεÄÒªº¦ÔÚÓÚ£º¶¨ÆÚ½øÐи¾¿Æ¼ì²é £¬¼°Ê±·¢ÏÖºÍÖÎÁƹ¬¾±°©Ç°²¡±ä £¬ÖÕÖ¹ÆäÏò¹¬¾±°©µÄÉú³¤¡£

 

        Ŀǰ¹¬¾±°©É¸²éÒªÁì¾ùȱ·¦ÌØÒìÐÔ £¬ÇÒÖ÷¹ÛÐÔÇ¿,³£µ¼ÖÂÁÙ´²Â©ÕïºÍÎóÕï¡£ËùÒÔ̽Ë÷Ò»ÖÖÐµĹ¬¾±°©É¸²é»ò·ÖÁ÷ÊÖ¶ÎÊ®·ÖÐëÒª¡£DNA¼×»ù»¯ÊÇÒ»ÖÖ³£¼ûµÄ±í¹ÛÒÅ´«·½Ê½,Ëæ×ÅDNA¼×»ù»¯¼ì²â¼¼ÊõµÄÉú³¤,ÆäÔÚÖ×ÁöÕïÁÆÁìÓò·¢»ÓÔ½À´Ô½´óµÄ×÷Óá£

 

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿

ͼƬÀ´Ô´£ºThe roles of m6A methylation in cervical cancer

 

Ò»¡¢¹¬¾±°©¼×»ù»¯

        DNA ¼×»ù»¯Êdz£¼ûµÄ±í¹ÛÒÅ´«µ÷¿ØÒªÁì £¬CpG µºÊdz¤¶ÈÔ¼ 1 kb µÄ¸»º¬ CpG ¶þºËÜÕËᣨ60%¡«70%£©µÄ DNA ÇøÓò £¬Í¨³£Î»ÓÚ»ùÒòµÄÆô¶¯×Ó»òµÚÒ»ÍâÏÔ×ÓÇøÓò £¬CpG µºµÄ¼×»ù»¯Óë»ùÒòµÄ³ÁĬÃÜÇÐÏà¹Ø £¬Ö×ÁöÒÖÖÆ»ùÒòÆô¶¯×ÓÇøÓò CpG µºµÄ¸ß¼×»ù»¯ÒýÆðÆäת¼³ÁĬ £¬¼ÓÈë°©Ö¢·¢ÉúºÍ½øÕ¹¹ý³Ì¡£

 

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿

ͼƬÀ´Ô´£ºCell Death and Disease (2023) 14:734

 

        ½üÄêÀ´·¢ÏÖÐí¶à¼×»ù»¯»ùÒò¿É×÷Ϊ¹¬¾±°©±êÖ¾Îï,ÔÚ¹¬¾±°©É¸²é¼°·ÖÁ÷·½Ãæ¾ßÓÐÓ¦ÓÃǰ¾°,¶øÇÒ¾ßÓÐÔ¤²â¼²²¡×ª¹éµÈÓÅÊÆ,ÓÐÀûÓÚ¹¬¾±°©µÄÔçÆÚÕï¶Ï¼°ÖÎÁÆ¡£

 

        DNA¼×»ù»¯¼ì²â¼¼Êõ¾ßÓп͹ۡ¢¸ßÖØ¸´ÐÔ¡¢ÓëÐźŷŴó¼ì²âµÈÌØÐÔ £¬ÇÒ¾ßÓÐ×Ó¹¬¾±°©Ôçɸ½Ï¸ßÌØÒìÐÔÓ뾫׼ÐÔ £¬ÊÇÒ»ÖÖÓÐDZÁ¦µÄ¹¬¾±°©É¸²éºÍ·ÖÁ÷ÊֶΡ£

 

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿

ͼƬÀ´Ô´£ºCell Death and Disease (2023) 14:734

 

¶þ¡¢È¨Íþ¹²Ê¶

     ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿

ͼƬÀ´Ô´£ºÍøÂç

 

        ¡¶À¶Æ¤Êé¡·ÖжԻùÒò¼×»ù»¯µÄÒâÒå¡¢»ùÒò¼×»ù»¯Ó빬¾±°©µÄ·¢Éú¡¢»ùÒò¼×»ù»¯ÔÚ¹¬¾±°©É¸²éÓë·ÀÖÎÖеÄÁÙ´²Ó¦ÓýøÐÐÁËÏêϸ½éÉÜ¡£

 

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿

ͼƬÀ´Ô´£ºÍøÂç

 

        ĿǰÎÒ¹ú×Ó¹¬¾±°©É¸²éÖ¸ÄÏÖеÄÒªÁìѧÖ÷ÒªÓÉϸ°ûѧ¼ì²é¡¢HPV¼ì²âºÍ´×ËáÈâÑÛÊӲ졣2021ÄêWHO¡¶×Ó¹¬¾±°©°©Ç°²¡±äɸ²éºÍÖÎÁÆÖ¸ÄÏ£¨µÚ2°æ£©¡·Ö¸³öδÀ´Ð¼¼Êõ £¬²¢¶Ô¹úÄÚ¾ßÓÐÁÙ´²Ö¤¾ÝÁ¦µÄ¼¼Êõ½øÐÐÕûÀí¡£ÆäÖÐDNA¼×»ù»¯¼ì²â¼¼Êõ¾ßÓп͹ۡ¢¸ßÖØ¸´ÐÔ¡¢ÓëÐźŷŴó¼ì²âµÈÌØÐÔ £¬ÇÒ¾ßÓÐ×Ó¹¬¾±°©Ôçɸ½Ï¸ßÌØÒìÐÔÓ뾫׼ÐÔ £¬ÊÇÒ»ÖÖÓÐDZÁ¦µÄ¹¬¾±°©É¸²éºÍ·ÖÁ÷ÊֶΡ£

 

ÄϹ¬(28NG¡¤¹ú¼Ê)¹Ù·½ÍøÕ¾-ÏàÐÅÆ·ÅÆÁ¦Á¿

ͼƬÀ´Ô´£ºÍøÂç

 

Èý¡¢ÄϹ¬28NGÏàÐÅÆ·ÅÆÁ¦Á¿¹¬¾±°©¼×»ù»¯¼ì²â

        ÎÒÃÇÈ«ÐÂÍÆ³ö¹¬¾±°©¼×»ù»¯¼ì²â £¬·¢Ñï¹ú¼Ò¹æ·¶»¯·ÀÖξ«Éñ £¬Ñϸñ×ñÊØ¡¶À¶Æ¤Êé¡·µÄÒªÇ󹿷¶ £¬Õë¶Ô¹¬¾±°©Ïà¹Ø»ùÒò½øÐÐDNA¼×»ù»¯¼ì²â £¬ºÏÀíÔ¤²â¹¬¾±°©·¢²¡·çÏÕ £¬¸¨Öú·ÀÖΡ¢¸üÈ«ÃæÖúÁ¦¹¬¾±°©É¸²é¡£

 

ÏîÄ¿ÓÅÊÆ

1¡¢DNA ¼×»ù»¯±êÖ¾ÎïÐÔÖÊÎȶ¨ £¬¿ÉÖØ¸´ÐÔ¸ß £¬½á¹û¸üΪ¿Í¹Û¡£

2¡¢DNA ¼×»ù»¯¼ì²âÄܹ»¼õÉÙ¶ÔÖÖÖÖÀàÐ͹¬¾±°©µÄ©ÕïÂÊ¡£

3¡¢DNA ¼×»ù»¯¼ì²â±ãÓÚ²ÉÑù¡£

 

ÊÊÓÃÈËȺ

? ÓмÒ×åÊ·

? ÉúÖ³µÀÒì³£³öѪ

? HPVѬȾµÈ

 

²Î¿¼ÎÄÏ×

[1] Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 2023;11:E197–E206.

[2] Lei JY, Arroyo-Muhr LS, Lagheden C, Eklund C, Kleppe SN, Elfstrom M, et al. Human papillomavirus infection determines prognosis in cervical cancer. J Clin Oncol. 2022;40:1522.

[3] Cibula D, Potter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer. Virchows Arch. 2018;473:391.

ÍøÕ¾µØÍ¼